日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India

贝伐珠单抗治疗实体恶性肿瘤患者的安全性、免疫原性和疗效的真实世界研究:一项在印度开展的IV期上市后研究

Sinha, Shubhadeep D; Biswas, Ghanashyam; Bheemareddy, Bala Reddy; Chary, Sreenivasa; Thakur, Pankaj; Jain, Minish; Maksud, Tanveer; Pawar, Suraj; Chatterjee, Koushik; Voonna, Murali Krishna; Goel, Anil; Puligundla, Krishna Chaitanya; Lakshmaiah, Kuntegowdanahalli Chinnagiriyappa; Talluri, Leela; Vattipalli, Ramya; Kakkunnath, Sheejith

Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study

达贝泊汀α(Hetero Biopharma)处方用于慢性肾脏病合并肾性贫血患者的安全性、耐受性和免疫原性:一项上市后监测研究

Sinha, Shubhadeep D; Bandi, Vamsi K; Reddy, Bala B; Thakur, Pankaj; Chary, Sreenivasa; Talluri, Leela; Kakkunnath, Sheejith